Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
IJID Regions|January 19, 2026
Corrigendum to 'Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study' [IJID Regions, volume 17 (2025) 100786]Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Cureus|December 18, 2023
Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological StudyPuneet Misra, Pramod K Garg, Amit Awasthi, et al.
Journal of Medical Virology|August 22, 2024
Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surgeAkshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Human Vaccines & Immunotherapeutics|April 28, 2023
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
Pageof 2